Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SYP.DE
Valuation Bad
0%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 43.95 1.86 1.29
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -120.00 -2.10 -0.95
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 6.77 46.76 43.80
Cash 29.77 10.85 8.36
Capex 5.41 -0.25 -0.27
Free Cash Flow 240.40 2.86 -0.84
Revenue -12.18 9.51 10.83
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -0.86 0.79 0.80
Operating Margin 4.69 0.23 0.22
ROA -37.64 0.03 0.04
ROE -39.34 0.04 0.07
ROIC -21.44 0.04 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SYP.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SYP.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SYP.DE is permitted for members.